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One of the first steps toward mounting an effective immune response to Mycobacterium 
tuberculosis (Mtb) is recognition of the pathogen through pattern-recognition receptors 
(PRRs) expressed by innate immune cells. Activation of the PRR Dectin-1 by an unknown 
mycobacterial ligand triggers an intracellular signaling cascade involving numerous pro-
teins, including spleen tyrosine kinase, protein kinase C-delta, and caspase recruitment 
domain family member 9, some of which have been shown to influence host immune 
response to TB infection. Here, we review the role of Dectin-1 signaling pathway in 
anti-mycobacterial immunity and discuss its contribution in the control of Mtb infection, 
and potential applications in TB vaccine adjuvanticity.
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inTRODUCTiOn
A critical function of the innate immune system is differentiating between cells or components 
which are “self,” and those of pathogenic microorganisms (1). Innate immune cells express pattern-
recognition receptors (PRRs) which recognize evolutionarily conserved microbial molecules, known 
as pathogen-associated molecular patterns (PAMPs) (2). Recognition via PRRs such as C-type lectin 
receptors (CLRs), NOD-like receptors, and toll-like receptors (TLRs) enable these cells to initiate 
responses to a broad range of potential pathogens.
When an innate immune cell, such as an alveolar macrophage, recognizes Mycobacterium tuber-
culosis (Mtb), a unique complement of PRRs will be activated. This triggers a signaling cascade within 
the innate cell, which results in the expression of immune modulators tailored to that pathogen. 
These immune modulators may trigger local inflammatory responses and provide the costimulation 
required for the activation and proliferation of adaptive immune cells, such as CD4+ T cells (2).
Understanding the role that PRR signaling plays in immunity to mycobacteria has been a recent 
research focus. Recent studies have shown that some receptors that activate the spleen tyrosine 
kinase (Syk)/caspase recruitment domain family member 9 (CARD9) signaling pathway may con-
tribute to anti-mycobacterial defense. Several CLRs that recognize mycobacteria are known to utilize 
this pathway, including Dectin-1, Dectin-2, Mincle, and Clecsf8 (3, 4). These receptors are briefly 
discussed below, and the rest of the review will discuss the importance of Dectin-1–Syk–CARD9 
signaling in orchestrating anti-mycobacterial immunity.
Syk/CARD9-COUPLeD CLRs in TB iMMUniTY
Dectin-2 recognizes mycobacterial mannosylated lipoarabinomannan (ManLAM) (5). This interac-
tion results in the recruitment of immunoreceptor tyrosine-based activation motif (ITAM)-linked 
FcRγ, which links to Syk and CARD9, resulting in a cascade of downstream signaling and cellular 
FigURe 1 | Dectin-1 structure. Dectin-1 consists of an extracellular C-type 
lectin domain, which is the carbohydrate-recognition domain (CRD) that 
binds ligands such as β-glucans. The CRD is attached by a stalk to a 
transmembrane region. Dectin-1 undergoes N-linked glycosylation on the 
CRD (mice) or stalk region (humans), shown in red and blue, respectively.  
The intracytoplasmic region comprises an immunoreceptor tyrosine-based 
activation motif- (ITAM)-like motif, or hemITAM, which initiates intracellular 
signaling.
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activation (5, 6). Dectin-2 also induces production of anti- and 
pro-inflammatory cytokines IL-2, TNF, MIP-2, IL-6, and IL-10, 
in DCs stimulated with ManLAM and BCG. The interaction of 
this CLR with ManLAM has also been shown to induce T-cell 
responses (5). Dectin-2 deficiency results in increased pathologi-
cal damage in mice infected with M. avium (5). Although Dectin-2 
has been shown to recognize pathogenic Mtb strain, H37Rv, the 
in vivo protective role of this receptor against this strain is yet to 
be demonstrated.
Mincle interacts with mycobacteria via trehalose 6,6′ dimy-
colate (TDM) (7, 8), the most abundant glycolipid on the cell 
wall of the bacilli (9). Like Dectin-2, this receptor is also coupled 
to the adaptor molecule, FcRγ, which initiates Syk-mediated 
cellular responses (9, 10). Mincle has been shown to trigger 
pro-inflammatory cytokine production and nitric oxide (NO) in 
macrophages stimulated with TDM or its synthetic analog, tre-
halose 6,6-dibehenate (TDB). TDB also induces Mincle-driven 
adaptive Th1 and Th17 responses when used as an adjuvant to 
subunit vaccines in mice (7, 8, 11). Despite these contributions to 
protective responses, Mincle has been shown to be dispensable 
for the control of Mtb infection in vivo (12), although contradict-
ing results have been reported (3, 4, 9).
Clecsf8 (MCL) is another FcRγ-coupled receptor that recog-
nizes mycobacterial TDM (13). This CLR is known to positively 
regulate the expression of Mincle through a protein–protein com-
plex interaction (14). Clecsf8-mediated cellular responses, which 
are dependent on the Syk/CARD9 complex, include phagocytosis, 
pro-inflammatory cytokine production, DC maturation, T-cell 
priming, and respiratory burst (14–16). Clecsf8-deficient mice are 
more susceptible to Mtb infection with increased lung bacillary 
loads, enhanced pathological damage with excessive neutrophilic 
infiltration, and early mortality (17). Clecsf8 polymorphisms are 
associated with TB susceptibility in humans (17).
Other Syk-coupled CLRs have been reported to recognize 
mycobacterial ligands. These have been reviewed elsewhere 
(4, 18), and they include DCAR, which recognizes glycolipds 
called PIMs (19), and SIGNR3, a DC-SIGN mouse homolog that 
recognizes ManLAM (20).
DeCTin-1 STRUCTURe AnD FUnCTiOn
Dectin-1 was initially identified by subtractive cDNA cloning, 
using mRNA extracted from murine DCs (21). This PRR is 
expressed on various myeloid cells, including macrophages and 
other mononuclear cells, as well as a subpopulation of T cells (22). 
Consistent with its role in pathogen surveillance (23), Dectin-1 
is highly expressed by immune cells residing in the mucosa of 
the lung (22) and gut (24). Dectin-1 is a glycosylated transmem-
brane receptor (type II) composed of two functional domains 
(see Figure  1). An extracellular C-type lectin domain (CTLD) 
binds β-glucans, polysaccharides that occur as (1  →  3)-β-D-
linked glucose polymers, mainly found on the surface of fungi, 
plants, and some bacteria (25). Dectin-1 may also bind ligands 
other than β-glucans (21), as evidenced by the observation that 
mycobacteria, which do not contain β-glucans on their cell 
wall, seem to interact with Dectin-1 through a yet to be identi-
fied ligand (26). The second functional domain is found on the 
intracellular tail region, which houses an ITAM-like motif, called 
hemITAM (23).
DeCTin-1 SignALing AnD iMMUne 
ReSPOnSeS
Dectin-1 initiates intracellular signaling via its hemITAM motif 
(Figure  2). Following ligand engagement by the CTLD, Src 
kinases mediate the tyrosine phosphorylation of the hemITAM 
domain (23), creating a docking site for Syk, which initiates a 
series of intracellular signaling cascades resulting in activation of 
the transcription factor nuclear factor κB (NF-κB) (23, 27, 28). 
Dectin-1 can also drive non-canonical activation of NF-κB by 
utilizing the serine-threonine kinase Raf-1 (29).
By influencing gene expression, Dectin-1 activation can lead to 
numerous downstream cellular responses, including expression 
of cytokines such as TNF-α, IL-2, IL-10 and IL-12, and CXCL2 
(28, 30, 31). Dectin-1-mediated activation can also induce phago-
cytosis (32) and respiratory burst (33). Furthermore, Dectin-1 
signaling has been shown to orchestrate adaptive immunity. 
DCs activated by Dectin-1 agonists are capable of differentiat-
ing naïve CD4+ T cells to a T helper- (Th-)1 or Th17 phenotype 
both in vitro and in vivo (34). Dectin-1-activated DCs can also 
induce the maturation and proliferation of CD8+ T cells in vitro: 
the Dectin-1 agonist curdlan was found to act as an adjuvant for 
cytotoxic T  lymphocyte cross-priming in  vivo, which elicited 
potent responses capable of protecting mice from experimental 
tumor challenges (35). Thus, Dectin-1 signaling serves as a link 
that generates appropriate adaptive responses following immune 
recognition (36).
FigURe 2 | Recognition of Mycobacterium tuberculosis (Mtb) by Dectin-1. An unknown Mtb ligand is recognized by Dectin-1, which is then tyrosine phosphorylated 
at its hemITAM residue by Src kinases (data not shown). This creates a docking site for spleen tyrosine kinase (Syk). Syk associates with a caspase recruitment 
domain family member 9 (CARD9)/B-cell lymphoma 10 (BCL-10)/mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) protein complex, 
resulting in activation of the transcription factor nuclear factor κB (NF-κB). Pro-inflammatory cytokine production follows, which induce an adaptive T cell response. 
Dectin-1-dependent signaling can also occur in neutrophils, where they induce reactive oxygen species (ROS) production.
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Dectin-1 does not appear to initiate protective responses in 
isolation, but acts synergistically with other receptors such as the 
TLRs. For instance, Dectin-1 stimulation was found to augment 
TLR-2-mediated production of cytokines in murine macrophages 
and DCs (30, 31). In addition, Ferwerda et al. showed that stimula-
tion of human peripheral blood mononuclear cells (PBMCs) with 
a Dectin-1 ligand, as well as ligands for TLR-2 or -4, led to a syn-
ergistic increase in TNF-α production compared with Dectin-1 
stimulation alone (37). Shin et al. extended this investigation to 
mycobacteria by infecting murine macrophages with M. abscessus 
(Mab), an environmental non-tuberculous Mycobacterium that 
can cause opportunistic infections in humans (38). The authors 
observed that Mab stimulation of macrophages initiated a physi-
cal colocalization between Dectin-1 and TLR-2 that was required 
for pro-inflammatory cytokine production (38). The mechanism 
underlying this apparent interaction remains to be elucidated 
(23, 39). In contrast to these findings, a study by Rothfuchs et al. 
showed that Dectin-1 inhibition significantly diminished the 
production of IL-12p40 by DCs lacking TLR-2 (40). This suggests 
that Dectin-1 signaling is not necessarily dependent on TLR-2. 
Notably, these conflicting studies described the effect of different 
microorganisms and stimuli on different cell types.
DeCTin-1 ReCOgniTiOn OF 
MYCOBACTeRiA
Dectin-1 has been well characterized as a major fungal β-glucan 
receptor (41). Interestingly, Dectin-1 has also been shown to 
be involved in the innate immune recognition of mycobacteria 
(26), which do not contain β-glucans (40). Yadav and Schorey 
established this by infecting murine bone marrow-derived mac-
rophages (BMDMs) with non-pathogenic M. smegmatis. They 
found that the production of TNF-α by BMDMs was decreased 
by approximately 60% in the presence of Dectin-1-blocking anti-
bodies (26). Moreover, they showed that Dectin-1 was required 
for the production of IL-6, G-CSF, and RANTES by BMDMs 
(26). However, when the authors performed infection using 
more virulent mycobacterial strains, such as Mtb strain H37Rv, 
they observed a significant decrease in the production of TNF-α 
compared with non-pathogenic strains, and this minimal TNF-
α production was not reliant on Dectin-1 (26). This suggested 
that the role of Dectin-1 in orchestrating immune responses to 
pathogenic mycobacteria is somewhat limited. In contrast to this 
finding, a later study by Rothfuchs et al. reported that Dectin-1 
does interact with pathogenic mycobacteria (40). These authors 
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demonstrated that murine splenic DCs (spDCs) infected with 
pathogenic Mtb produced significantly less IL-12p40 when treated 
with laminarin, a competitive inhibitor of Dectin-1 (40). Thus, 
Dectin-1 is involved in the recognition of the important human 
pathogen Mtb as well as less virulent mycobacteria. Rothfuchs 
et  al. went on to show that pharmacological Syk inhibition 
reduced the capacity of spDCs to produce IL-12p40 upon Mtb 
exposure, suggesting that this response was Syk dependent (40). 
The authors also elegantly confirmed the presence of a Dectin-1 
ligand on mycobacteria, by showing that a Dectin-1–Fc fusion 
protein (42) was capable of binding live M. bovis (40). These and 
other related studies established the role of Dectin-1-mediated 
responses in non-human innate immune cells. The role of this 
CLR in human cells was investigated more recently.
Although they are not traditionally considered to be immune 
cells, airway epithelial cells may serve an important function in 
mediating pulmonary immune responses. These cells express 
PRRs such as Dectin-1, albeit to a lesser extent than myeloid cells. 
Lee et  al. reported that Mtb could induce Dectin-1 expression 
in human A549 airway epithelial cells in a TLR-2-dependent 
fashion (43), and such expression contributed to the production 
of reactive oxygen species (ROS), antimicrobial peptides, and 
pro-inflammatory cytokines by these cells (43). Another inves-
tigation into mycobacteria-induced Dectin-1 signaling in human 
cells was undertaken by Zenaro et  al. These authors observed 
that Mtb infection induced the maturation of monocyte-derived 
DCs (MDCs), as well as the Dectin-1-dependent production of 
IL-1β, IL-6, IL-23, and TNF-α (44) by these cells. In addition, 
DCs activated with a Dectin-1 agonist stimulated naïve CD4+ 
T cells to secrete IFN-γ and IL-17 (44). Another study has dem-
onstrated that simultaneous activation of neonatal MDCs with 
agonists of Dectin-1 and TLRs promote synergistic production of 
IL-12p70 (45). In human PBMCs stimulated with Mtb, Dectin-1 
and TLR-4 are the main receptors driving IL-17A production 
(46). Interestingly, administration of Dectin-1 agonist, curdlan, 
together with a mycobacterial antigen TB10.4, induced Th1 and 
Th17 responses in neonatal mice infected with Mtb (45). A recent 
study by Bisiaux et al. investigated cell-specific activation and pro-
inflammatory responses in human whole blood stimulated with 
BCG (47). Interestingly, Dectin-1/2 responses were predomi-
nantly activated in neutrophils when compared with monocytes 
and lymphocytes populations. This work also demonstrated that 
induction of ROS production by BCG was decreased by neu-
tralization of Dectin-1/2 and TLR-2/4 in both neutrophils and 
monocytes (47). In agreement with these findings, a recent report 
has shown that Mtb can induce DC maturation by generating ROS 
production through Dectin-1/TLR-2 (48). These in vitro findings 
indicated that Dectin-1 signaling is involved in the stimulation 
and activation of neutrophils and antigen-presenting cells (APCs), 
which lead to adaptive anti-mycobacterial immune responses.
To explore the significance of Dectin-1 in  vivo, Marakalala 
et  al. investigated Dectin-1-deficient mice and wild-type (WT) 
controls infected with aerosolized Mtb (49). The kncokout mice 
had significantly and reproducibly decreased (~0.5 log) pulmo-
nary bacillary burdens (49). However, both the Dectin-1-deficient 
and WT mice developed similar histological signs of pneumonia, 
suggesting that there was still profound inflammatory activation 
in Dectin-1-deficient mice despite their decreased bacterial bur-
den. Indeed, Dectin-1 deficiency did not result in any significant 
and reproducible changes in the pulmonary cytokine expression 
profiles compared with WT controls (49). The authors also found 
that Dectin-1 deficiency did not significantly affect mouse sur-
vival 150 days of post-infection. Marakalala et al. concluded that 
Dectin-1 does not play a major role in immunity to Mtb in vivo 
and acknowledged the potential significance of the mechanisms 
underlying the decreased bacillary burden conferred by Dectin-1 
deficiency.
THe FUnCTiOn OF Syk in PRR 
SignALing AnD iMMUniTY TO Mtb
Spleen tyrosine kinase is an intracellular signal transducer that 
performs diverse biological functions, including innate immune 
recognition (50). Syk can be activated by associating with the 
phosphorylated ITAM or hemITAM motif of CLRs via one of 
its two SH2 domains. In the case of the Dectin-1/Syk pathway, 
Syk activates protein kinase C-delta (PKCδ) which mediates 
the phosphorylation of CARD9 (51). This enables CARD9 to 
associate with B-cell lymphoma 10 and the paracaspase mucosa-
associated lymphoid tissue lymphoma translocation protein 1 
(MALT1) to form a trimolecular structure capable of canonically 
activating NF-κB (52, 53). Such manipulation of gene expression 
allows Syk to exert its secondary messenger functions, trigger-
ing ROS production (33), accelerated phagocytosis (28), and 
the production of pro-inflammatory cytokines, such as IL-1β, 
IL-6, IL-12, and TNF-α (18). Mature IL-1β production requires 
further post-translational modification of pro-IL-1β by a caspase-
1-containing oligomer called an inflammasome (50). The NLPR3 
inflammasome is activated in a Syk-dependent mechanism by 
mycobacteria that express the virulence factor ESAT6, and such 
activation has been linked to macrophage necrosis (54). There is 
therefore mounting evidence that this signaling molecule may be 
relevant in immune responses to mycobacterial infections.
Spleen tyrosine kinase is involved in a multitude of biological 
functions, and therefore essential for normal survival in mice 
(55). This makes it difficult to determine the effect of Syk defi-
ciency on mycobacterial immunity in vivo, for example, using a 
gene knockout study in mice. Better research tools are required 
to understand the role of Syk in mycobacterial infections in vivo 
and in humans.
PKCδ AnD iMMUniTY TO Mtb
As already described, CLRs which activate Syk are linked to the 
CARD9–BCL10–MALT1 pathway. Strasser et  al. showed that 
the linker molecule PKCδ is activated by Syk and mediates the 
phosphorylation of CARD9 (51). The role of this kinase in signal 
transduction prompted Parihar et al. to investigate the relevance 
of PKCδ function following Mtb infection (56). They observed 
that mice deficient in PKCδ (either through gene knockout or 
pharmacological inhibition) were less resistant to Mtb, display-
ing more severe lung pathology, excessive pro-inflammatory 
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cytokine production, increased bacterial burdens, and increased 
mortality compared with their WT or untreated controls. Using 
gene expression profiles from Mtb-infected humans, the authors 
showed that PKCδ abundance was temporally associated with 
progression to TB disease. In addition, the authors analyzed lung 
specimens from TB patients and found that PKCδ was highly 
expressed in necrotic and cavitary granulomas (56). These data 
indicate that PKCδ is an important determinant of Mtb infection 
in humans and mice.
CARD9 AnD iMMUniTY TO Mtb
CARD9 is an adaptor protein involved in the Dectin-1/Syk sign-
aling cascade and is expressed in DCs and macrophages (52). The 
adaptor picks up on signals from multiple receptor classes, such 
as ITAM-based receptors (including CLRs) and TLRs (27). The 
role of CARD9 in Mtb immunity was evaluated by Dorhoi et al. 
using a mouse model of Mtb H37Rv infection (57). These authors 
demonstrated that CARD9-deficient mice had a reduced ability 
to control bacterial replication, developed severe lung pathology, 
and displayed increased mortality compared with their littermate 
controls (57). Infected CARD9-deficient mice developed acute 
pneumonia, and histological examination of the lungs revealed 
the presence of necrotic foci and an inflammatory infiltrate with 
profound neutrophil accumulation. Moreover, lung specimens 
from CARD9-deficient mice showed increased apoptotic cell 
death and secondary necrosis compared with WT controls (57). 
There is evidence to suggest that the mobilization of neutrophils 
from the bone marrow to peripheral tissues is dependent on 
the cytokines G-CSF and CXCL1 (58), and these cytokines 
were significantly elevated in the sera of CARD9-deficient mice 
compared with their littermate controls (57). The investigators 
also demonstrated that neutrophils deficient in CARD9 were 
unable to produce the regulatory cytokine IL-10 when challenged 
with Mtb, leading to deregulated pulmonary inflammation (57). 
These data led the authors to conclude that CARD9 is required 
for properly regulated innate immune cell activation during Mtb 
infection.
To further explore the mechanism of CARD9 function in TB, 
Dorhoi et  al. infected APCs with Mtb H37Rv and found that 
deficiency in the CARD9 adaptor did not affect NO synthesis 
by the APCs nor did it affect the phagocytosis or destruction of 
Mtb following IFN-γ activation (57). However, CARD9-deficient 
BMDMs produced significantly less TNF-α, IL-1β, IL-6, IL-12, 
and CCL5 compared with WT controls (57). Given the reduced 
levels of IL-12 in their in  vitro experiments, one might have 
expected to see impaired Th1 responses in  vivo (as IL-12 con-
tributes to Th-1 polarization). However, no such aberrations in 
T cell recruitment and activation were observed in the lungs of 
infected CARD9-deficient mice (57). Similarly, the authors did 
not observe any deficit in Th17 responses in CARD9-deficient 
mice (57), even though an earlier study demonstrated that the 
Syk/CARD9 pathway is required for developing Th17 responses 
to Candida albicans (34). Nevertheless, adequate T-cell responses 
were not able to overcome the pathology induced by defects in 
innate immune cell inflammatory activation. These results sug-
gest an essential role for CARD9 in anti-mycobacterial immunity.
THe Syk/CARD9 PATHwAY in TB 
vACCinOLOgY
To generate a protective immune response to Mtb, antigen-specific 
Th1 cells are required (59). In addition, the generation of Th17 cells 
secreting IL-17 has been shown to augment a protective host response 
by stimulating the influx of effector cells to the areas of infection 
(60). An effective vaccine to Mtb would probably need to activate 
APCs in such a way that they “instruct” T cell differentiation to 
Th1 and Th17 phenotypes. One novel vaccination strategy involves 
using recombinant Mtb antigens as subunit vaccines; however, these 
vaccines have not been successful on their own, perhaps because 
in themselves they do not activate APCs. This necessitates the use 
of vaccine adjuvants capable of triggering helpful innate cellular 
responses to guide adaptive immunity. Potential adjuvants include 
the mycobacterial PAMPs TDM and its synthetic analog TDB, 
which induce protective Th1 and Th17 immunity by activating APCs 
via the Syk–CARD9–BCL10–MALT1 pathway (11). The major 
PRRs that bind TDM are Mincle (7, 8) and Clecsf8 (13, 17), 
suggesting that signaling initiated by either one or both of these 
CLRs via the Syk/CARD9 pathway may be essential for protective 
immunity to Mtb.
COnCLUSiOn AnD FUTURe DiReCTiOnS
An important step toward a deeper understanding of Dectin-1–
Syk–CARD9 signaling will be identifying the mycobacterial 
PAMP recognized by Dectin-1. This would help elucidate how 
Mtb interacts with human innate immune cells, and how this 
contributes to or lessens pathology. β-Glucans are currently the 
only known Dectin-1 ligand, yet Dectin-1 recognizes mycobacte-
ria, which do not express β-glucans. The nature of the ligand will 
therefore broaden our knowledge of Dectin-1 PAMP recognition.
Dectin-1 itself may not be essential for Mtb immunity, but 
some of the downstream signaling molecules such as CARD9 
evidently are. The effect of other signaling molecules, like Syk 
and PKCδ, in Mtb responses remains to be fully elucidated. In 
addition, future studies should look at how CLRs that utilize this 
signaling pathway interact, perhaps by performing gene knock-
outs of multiple receptors in mice. Although Dectin-1 appears 
to play a minor role in in  vivo Mtb immunity, components of 
Dectin-1/Syk signaling can induce protective downstream host 
responses, and this pathway remains a potential target for vaccine 
adjuvants.
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